The WHO did not make any recommendation on the use of the drugs for severe and critical cases of COVID-19. Read More

Conditionally authorized in the EU since December 2021, the vaccine received emergency use authorization from the FDA on July 13. Read More

The FDA said confirmation with a molecular assay may be necessary. Read More

The FDA has granted Emergency Use Authorization (EUA) to Novavax’s COVID-19 vaccine. Read More

This isn’t the first time the companies have been accused of patent infringement with regard to their COVID-19 vaccines. Read More

The vaccine received Emergency Use Authorization for this specific pediatric population in May 2021. Read More

CureVac has filed a patent infringement lawsuit against BioNTech, claiming its messenger RNA (mRNA) technology was used without credit or compensation to create BioNTech’s and Pfizer’s Comirnaty, the world’s first approved COVID-19 vaccine and now the most widely used one. Read More

The FDA has revised the Emergency Use Authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir and ritonavir) to allow state-licensed pharmacists to prescribe the oral antiviral drug to COVID-19 patients. Read More

Only 2.3 million Canadians had received at least one dose of this specific vaccine. Read More

REGEN-COV doses are being stored for possible use against future COVID-19 variants. Read More

No studies have been conducted yet on modified vaccines containing an Omicron BA.4/5 component. Read More

Innova’s rapid antigen self-test detects multiple proteins in the SARS-CoV-2 virus. Read More